3 results match your criteria: "Pessac University Hospital[Affiliation]"
Unusual Postoperative Course After Tendyne Implantation.
Circ Cardiovasc Imaging
September 2022
Department of Cardiology and Cardio-Vascular Surgery, Hôpital Cardiologique de Haut-Lévèque, Pessac University Hospital, France (A.P., M.P., J.T.).
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.
J Crohns Colitis
May 2020
Gastroenterology Unit, University Hospital of Saint Etienne, Saint-Etienne, France.
Biologic therapies have revolutionized the management of inflammatory bowel disease [IBD], but primary and secondary non-responses occur in a significant proportion of patients. Therapeutic drug monitoring [TDM] now has an established role in the treatment algorithm for managing secondary loss of response to anti-tumour necrosis factor [anti-TNF] agents during maintenance therapy. Data to support the use of TDM in the management of secondary loss of response to vedolizumab and ustekinumab are emerging.
View Article and Find Full Text PDFLiver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?
Aliment Pharmacol Ther
April 2017
Liver-Gastroenterology Department, University Hospital, Angers, France.
Background: In chronic hepatitis C, the European Association for the Study of the Liver and the Asociacion Latinoamericana para el Estudio del Higado recommend performing transient elastography plus a blood test to diagnose significant fibrosis; test concordance confirms the diagnosis.
Aim: To validate this rule and improve it by combining a blood test, FibroMeter (virus second generation, Echosens, Paris, France) and transient elastography (constitutive tests) into a single combined test, as suggested by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America.
Methods: A total of 1199 patients were included in an exploratory set (HCV, n = 679) or in two validation sets (HCV ± HIV, HBV, n = 520).